We are live on
!
Find out more
Fundsmith LLP Portfolio holdings
AUM
$13.6B
1-Year Est. Return
7.6%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+7.6%
3 Year Est. Return
+53.18%
5 Year Est. Return
+52.54%
10 Year Est. Return
+342.88%
AUM
$22B
AUM Growth
-$1.48B
(-6.3%)
Cap. Flow
-$1.5B
Cap. Flow
% of AUM
-6.81%
Top 10 Holdings %
Top 10 Hldgs %
69.17%
Holding
40
New
2
Increased
5
Reduced
20
Closed
2
Avg Time Held
19
quarters
Top 10 Avg Time Held
17.1
quarters
Top 20 Avg Time Held
21.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$386M |
| 2 |
Texas Instruments
TXN
|
+$192M |
| 3 |
Intuit
INTU
|
+$109M |
| 4 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$48.4M |
| 5 |
Doximity
DOCS
|
+$30.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$861M |
| 2 |
Meta Platforms (Facebook)
META
|
+$437M |
| 3 |
Microsoft
MSFT
|
+$333M |
| 4 |
Visa
V
|
+$164M |
| 5 |
Automatic Data Processing
ADP
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.52% |
| 2 | Technology | 23.68% |
| 3 | Consumer Staples | 17.04% |
| 4 | Communication Services | 15% |
| 5 | Consumer Discretionary | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Qualys
QLYS
$7B
| $90.5M | 0.41% |
718,602
+170,593
| +31% | +$23.1M |
2020 Q2
19 quarters
|
|
27
Paycom
PAYC
$10.5B
| $90.3M | 0.41% |
413,510
+90,899
| +28% | +$19.2M |
2018 Q4
25 quarters
|
|
28
Clorox
CLX
$10.1B
| $90.3M | 0.41% |
613,497
| – | – |
2023 Q4
5 quarters
|
|
29
Rollins
ROL
$15.4B
| $86.3M | 0.39% |
1,597,513
| – | – |
2021 Q1
16 quarters
|
|
30
ODDITY Tech
ODD
$974M
| $69.9M | 0.32% |
1,615,158
| – | – |
2023 Q3
6 quarters
|
|
|
31
Doximity
DOCS
$5.44B
| $69M | 0.31% |
1,189,882
+479,380
| +67% | +$30.3M |
2024 Q4
1 quarter
|
|
32
Exponent
EXPO
$3.32B
| $67.8M | 0.31% |
836,477
| – | – |
2023 Q2
7 quarters
|
|
33
Sabre
SABR
$767M
| $60.4M | 0.27% |
21,499,095
| – | – |
2018 Q4
25 quarters
|
|
34
Equifax
EFX
$17.1B
| $57.4M | 0.26% |
235,505
-127,823
| -35% | -$32.1M |
2018 Q4
25 quarters
|
|
|
CPRX
35
DELISTED
Catalyst Pharmaceutical
CPRX
| $52.2M | 0.24% |
+2,151,274
| New | +$48.4M |
2025 Q1
0 quarters
|
|
36
Home Depot
HD
$290B
| $42M | 0.19% |
114,736
-30,903
| -21% | -$12M |
2021 Q1
16 quarters
|
|
37
Medpace
MEDP
$17.1B
| $38.9M | 0.18% |
127,537
| – | – |
2024 Q4
1 quarter
|
|
38
Mastercard
MA
$516B
| $27.1M | 0.12% |
49,454
-14,579
| -23% | -$7.94M |
2023 Q1
8 quarters
|
|
39
IDEX
IEX
$17.3B
| – | – |
-362,501
| Closed | -$75.9M | – |
|
|
40
PepsiCo
PEP
$172B
| – | – |
-5,663,677
| Closed | -$861M | – |
|
Similar funds
JIC
BGC
PMAM
MGIA
BHCM
HRCM
DWM
VA
Fundsmith LLP's Q1 2025 Portfolio in Review
As of Q1 2025, Fundsmith LLP held 40 positions worth $22B, down 6.3% from $23.5B the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Fundsmith LLP withdrew a net $1.5B in Q1 2025, closing 2 positions and reducing 20 holdings. Its most notable exit was PepsiCo, an estimated $861M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Fundsmith LLP opened a new position in Intuit worth $112M.
- Fundsmith LLP's largest Q1 2025 buy was Intuit: 181,628 shares worth $112M.
- Fundsmith LLP added most to Zoetis in Q1 2025, an estimated $386M increase.
- Fundsmith LLP's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $437M.
- Fundsmith LLP fully exited PepsiCo in Q1 2025, selling an estimated $861M.
- Fundsmith LLP's ten largest holdings make up 69% of its $22B portfolio in Q1 2025.
- Fundsmith LLP opened 2 new positions and closed 2 in Q1 2025.
- Fundsmith LLP's portfolio value fell 6.3% quarter-over-quarter to $22B.
Based on Fundsmith LLP's 13F filing for Q1 2025, filed 15 May 2025.